EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Situ Proliferating Peptide Nanoparticle Augments Multi‐Target Intervention of Secondary Brain Damage Following Subarachnoid Hemorrhage

Yibin Zhang, Peisen Yao, Fuxiang Chen, Shufa Zheng, Xuegang Niu, Haojie Wang, Yuanxiang Lin, Bin Gao, Dezhi Kang iD

Advanced Science · 2025-08 · 12 (31)

DOI: 10.1002/advs.202417456 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 30.05.2025. Verfasst von Yibin Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Neurosurgery Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, 350005, China. Hauptthemen laut MEDLINE: Subarachnoid Hemorrhage, Nanoparticles, Peptides, Brain Injuries. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Major Scientific Research Specialty Project of Fujian Province, China, Major Scientific Research Program for Young and Middle-aged Health Professionals of Fujian Province, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Subarachnoid hemorrhage (SAH), a lethal stroke subtype, involves complex pathological cascades triggered by neuro‐glial units for persistent neuroinflammation, oxidative damage and programmed neuronal cell death. Single‐target and traditional multi‐target therapies, derived from individual drugs, show limited efficacy in addressing these interconnected events, due to spatiotemporal heterogeneity of action in single‐target components. This highlights the urgent need for not only new therapeutic targets, but advanced multi‐target drugs. Herein, we identify elevated cell‐free DNA (cfDNA), a key neuroinflammatory driver, as correlated with SAH severity and poor prognosis, suggesting its therapeutic potential. Furthermore, a novel “in situ proliferation” strategy is proposed and a flexible multi‐target peptide nanoparticle is developed through co‐assembling matrix metalloproteinase‐2 responsive cationic peptide and glutathione peroxidase‐mimicking peptide (GPXP). Upon reaching injury lesions, this system splits into two individual drugs: cationic peptide scavenges pathological cfDNA and inhibits microglia‐mediated neuroinflammation, while GPXP protects neurons against oxidative damage and neuronal apoptosis/ferroptosis. Consequently, this strategy proves superior therapeutic effects on reducing secondary brain injury and promoting neurofunctional recovery in SAH mice. These findings not only highlight the essential role of cfDNA in SAH but offer a flexible resolution to advance multi‐target combinational therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Subarachnoid HemorrhageNanoparticlesPeptidesBrain InjuriesAnimalsMiceMaleHumansDisease Models, AnimalOxidative StressMice, Inbred C57BL

Stichwörter der Autor:innen

MMP‐2 responsivenessmulti‐target of combinationpeptide nanoparticlesecondary brain injurysubarachnoid hemorrhage

Substanzen

Peptides

Autor:innen und Institutionen

  • Department of Neurosurgery, Neurosurgery Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, 350005, China.
  • Department of Neurosurgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350212, China.
  • Fujian Provincial Institutes of Brain Disorders and Brain Sciences, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, 350005, China.

ORCID-Profile: Dezhi Kang

Förderung

  • National Natural Science Foundation of China
  • Major Scientific Research Specialty Project of Fujian Province, China
  • Major Scientific Research Program for Young and Middle-aged Health Professionals of Fujian Province, China
  • Joint Funds for the Innovation of Science and Technology, Fujian Province, China
  • Natural Science Foundation of Fujian Province, China
  • Fujian Provincial Health Technology Project

Zitieren

APA

Zhang, Y., Yao, P., Chen, F., Zheng, S., Niu, X., Wang, H., Lin, Y., Gao, B., & Kang, D. (2025). In Situ Proliferating Peptide Nanoparticle Augments Multi‐Target Intervention of Secondary Brain Damage Following Subarachnoid Hemorrhage. Advanced Science, 12(31). https://doi.org/10.1002/advs.202417456

Vancouver

Zhang Y, Yao P, Chen F, Zheng S, Niu X, Wang H, et al. In Situ Proliferating Peptide Nanoparticle Augments Multi‐Target Intervention of Secondary Brain Damage Following Subarachnoid Hemorrhage. Advanced Science. 2025;12(31). doi:10.1002/advs.202417456

BibTeX
@article{Zhang2025,
  author = {Zhang, Yibin and Yao, Peisen and Chen, Fuxiang and Zheng, Shufa and Niu, Xuegang and Wang, Haojie and Lin, Yuanxiang and Gao, Bin and Kang, Dezhi},
  title = {In Situ Proliferating Peptide Nanoparticle Augments Multi‐Target Intervention of Secondary Brain Damage Following Subarachnoid Hemorrhage},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {31},
  doi = {10.1002/advs.202417456}
}
Kostenlos starten →